Milk Residues Following Multiple Doses of Meloxicam and Gabapentin in Lactating Dairy Cattle

報告時間:2026-11-04
報告地點:大四教室
指導老師:Chien-Kai Wang
學生:Ting-Chin Lu
摘要
Cattle can experience pain and inflammation due to conditions such as hoof disease, which can affect their welfare. Anti-inflammatory and analgesic drugs can be used to help relieve these problems. Meloxicam is a nonsteroidal anti-inflammatory drug (NSAID) that reduces pain and inflammation mainly by inhibiting cyclooxygenase and decreasing prostaglandin production. Gabapentin is an analgesic drug that acts differently by binding to the α2δ subunit of voltage-gated calcium channels and reducing neurotransmitter release. However, when these drugs are used in lactating dairy cattle, milk residues and potential food safety concerns also need to be considered. Therefore, the pharmacokinetics and milk residues of meloxicam and gabapentin after repeated administration were investigated, and the effects of lactation stage and co-administration on their pharmacokinetics were evaluated. Postpartum (PP) and mid-lactation (ML) dairy cows received oral meloxicam at 1 mg/kg for 6 consecutive days, either alone or combined with gabapentin at 20 mg/kg. Plasma and milk samples were collected to determine drug concentrations using UPLC-MS/MS, and pharmacokinetic parameters were calculated using noncompartmental analysis. The results showed that the terminal half-life of meloxicam in plasma was longer in PP cows than in ML cows, while no significant difference was found in milk. Co-administration of gabapentin did not significantly affect meloxicam concentrations in plasma or milk. Gabapentin pharmacokinetic parameters also did not differ significantly between PP and ML cows, and overall drug exposure in milk was lower than that in plasma. Following the final dose, meloxicam and gabapentin concentrations in milk fell below the limit of detection at 120 and 60 hours, respectively, in all cows. Overall, lactation stage may affect the plasma pharmacokinetics of meloxicam, whereas co-administration of gabapentin did not substantially alter the pharmacokinetic characteristics of either drug. Following multiple dosing, drug concentrations in milk gradually decreased over time, providing useful information on milk residues in lactating dairy cattle.
  • Brune K, P. Patrignani. (2015). New insights into the use of currently available non-steroidal anti-inflammatory drugs. Journal of Pain Research, 8, 105–118.
  • Chincholkar, M. (2020). Gabapentinoids: Pharmacokinetics, pharmacodynamics and considerations for clinical practice. British Journal of Pain, 14(2), 104–114.
  • Mzyk, D. A., C. B. Giles, R. E. Baynes, and G. W. Smith. (2023). Milk residues following multiple doses of meloxicam and gabapentin in lactating dairy cattle. Journal of the American Veterinary Medical Association, 261(12), 1873–1879.
  • Zoltick, A. H., S. Mann, and J. F. Coetzee. (2024). Pain pathophysiology and pharmacology of cattle: How improved understanding can enhance pain prevention, mitigation, and welfare. Frontiers in Pain Research, 5, 1396992.